Dear Members of the UCSF Community,
I am delighted to share the news that in 2018, for the 12th consecutive year, UCSF was awarded more funding from the National Institutes of Health (NIH) than any other public university in the United States, and the second most overall.
Our four schools of Dentistry, Medicine, Nursing, and Pharmacy, along with our Graduate Division, earned a record amount totaling more than $647.8 million of these highly competitive contracts and grants, which support research into the fundamental underpinnings of life, the development of treatment strategies for the full spectrum of human diseases, and training for the next generation of researchers and clinicians. The schools of Dentistry, Medicine and Pharmacy topped the nation in federal funding in their fields, and the School of Nursing received the most of any public nursing school and the second most overall nationwide. Read more about this accomplishment.
This marks the first time that UCSF has surpassed $600 million, and it represents UCSF’s largest increase in NIH funding (9.09 percent) since 2011. Our success in competing for NIH funds reflects the high caliber of scientific discovery underway across UCSF.
NIH funding is the lifeblood of our research enterprise, enabling our faculty, staff, students, and trainees to confront problems and answer questions in the biomedical sciences, from curiosity-driven research to the application of those discoveries to patients and populations.
We remain vigilant in our...
Dear Members of the UCSF Community,
I am writing to share some exciting news with you regarding Ron Vale, PhD, professor in the Department of Cellular and Molecular Pharmacology. Ron has been named executive director of the Janelia Research Campus of the Howard Hughes Medical Institute (HHMI), in Ashburn, Virginia, and an HHMI vice president. He will begin this new post in early 2020 and will continue to hold a faculty appointment at UCSF.
A gifted and versatile researcher, Ron has made fundamental contributions to biology and is a champion of openness and clarity in communicating research, whether among scientists themselves or between scientists and the general public. We are privileged to count him as a colleague, and he is an ideal choice to lead the world-class scientific enterprise at Janelia.
For his seminal research on the molecular motors known as kinesin and dynein, Ron has received some of the most prestigious prizes in biomedical research, including the Albert Lasker Basic Medical Research Award and the Shaw Prize in Life Sciences and Medicine.
Our faculty are world-renowned, and their accomplishments are a source of great pride for the university. UCSF is known for attracting great leaders, but just as importantly for celebrating those who embark on a new chapter.
Please join me in congratulating Ron Vale on his remarkable achievements and in sending him our best wishes for continued success.
Read more online about Ron’s career at UCSF and his HHMI appointment.
Sincerely,
Sam Hawgood, MBBS
Chancellor
Arthur and Toni Rembe Rock Distinguished Professor